How the GLP-1 Bridge Works

Last Updated: July 6, 2026

Think of the GLP-1 Bridge as a separate lane from your regular Medicare drug coverage. It runs alongside your Part D plan, not through it. That means your existing drug plan doesn't need to approve anything — the Bridge has its own process, its own administrator, and its own pricing.

CMS — the federal agency that runs Medicare — created the Bridge as a short-term demonstration program. It runs from July 1, 2026 through December 31, 2027. It was designed for people who can't get GLP-1 coverage for weight management through their current Part D plan.¹

Three drugs are covered under the Bridge when prescribed specifically for weight management:

• Foundayo — an oral tablet

• Wegovy — available as an injection or tablet

• Zepbound — the KwikPen version only (the single-dose pen and vials are not covered)

If you're prescribed one of these for a different condition — like type 2 diabetes or sleep apnea — the Bridge doesn't apply. Those prescriptions go through your regular Part D plan as they normally would.²

SOURCES

1. "Medicare GLP-1 Bridge." Centers for Medicare & Medicaid Services. cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge. Accessed June 2026.
   
   
2. "Medicare GLP-1 Bridge: Information for Prescribers." Centers for Medicare & Medicaid Services, June 2026. cms.gov/files/document/glp-1-prescribers-c-1.pdf. Accessed June 2026.